ENTITY

Kyowa Kirin Co Ltd (4151 JP)

Analysis

Health Care • Japan

Kyowa Hakko Kirin Co.,Ltd. develops, manufactures, and markets pharmaceuticals. The Company's products include a protein produced by genetic recombination technology, an anti-anemia agent that attaches new sugar chains through partial modification of the amino acid sequence of human erythropoietin (EPO), and a glycoprotein, human erythropoietin.

Refresh

Company Event • 26 Nov 2024 09:00 • Upcoming

Add To Calendar

Investor Day 2024

Company Event • 06 Feb 2025 14:00 • Upcoming

Add To Calendar

Q4 2024

Company Event • 21 Nov 2024 06:30 • Upcoming

Add To Calendar

Collaboration

Company Event • 31 Oct 2024 16:00 • Upcoming

Add To Calendar

Q3 2024

Company Event • 31 Oct 2024 14:00 • Upcoming

Add To Calendar

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00